Pharmaceutical companies are robbing people by "involution"!

The continuous enhancement of the competitiveness of local pharmaceutical companies has formed a strong attraction for overseas R&D talents; pharmaceutical companies, including traditional pharmacies, are actively exploring new marketing channels to expand the market; Shows strong vitality under empowerment;

In the context of the accelerated development and industrial optimization and upgrading of the domestic pharmaceutical industry, the pharmaceutical industry needs a lot of talent support, and talent needs and gaps, mobility trends, and salary levels are becoming the concerns of both recruiters and practitioners

A few days ago, Career International released the "2022 Talent Market Insights and Salary Guide" to show us the talent needs and gaps in various segments of the medical and health industry in 2022, the flow trend and the continuously rising salary level

The "Healthy China 2030" Planning Outline clearly states that by 2030, the scale of the health industry will expand significantly and become a pillar industry of the national economy

With the continuous changes in various fields of the general health industry, the medical subdivisions are ushering in rapid development, digital technology is reshaping the future of the medical and health industry, and the demand for talents in the general health field continues to be strong.

In the post-epidemic era, with the deepening of the reform of the medical security system, the continuous implementation of medical and medical insurance policies, the promotion of centralized procurement and use of drugs organized by the state, and the implementation of a series of reforms and policies, such as the state’s promotion of medical innovation, the pharmaceutical industry is moving towards a new Times move forward

01.

With the guidance and encouragement of pharmaceutical policies and the improvement of the innovation environment in recent years, the demand for innovative R&D personnel in the pharmaceutical market has become more and more obvious.

Thanks to the favorable pharmaceutical innovation environment and favorable policies in the past few years, the number of biomedical technology companies and the number of innovative drugs under development have shown explosive growth

The epidemic has accelerated the development of the pharmaceutical industry

The emergence of new technologies has created new job gaps

Judging from the current salary and job-hopping increase of popular positions in the field of pharmaceutical research and development, mRNA executives, gene therapy CSOs, and cell therapy CTOs are popular positions, with an annual salary of 1.

In the process of rapid development and industrial optimization and upgrading of the entire pharmaceutical industry, both the clinical development field and the manufacturing sector are faced with a huge talent gap

As we all know, talents are the basis for the sustained and rapid development of pharmaceutical R&D

With the rise of the new drug R&D market and the continuous introduction of relevant policies, there is still a large shortage of talents to undertake key clinical development tasks

The industries that participate in the clinical trials of new drugs are all in short supply industries.

Some CEOs of innovative pharmaceutical companies believe that the personnel in the clinical trial industry are less stable than R&D personnel, and the turnover of personnel is large, and the growth rate of wages must be faster
.
On the one hand, it reflects the rapid development of the pharmaceutical industry and the increasing demand for talents involved in clinical trials
.
On the other hand, this situation will exacerbate the instability of personnel in the clinical trial industry, which also brings great losses to the company
.

In general, the current talent gap in the field of clinical development is mainly in medical, clinical, and registration positions
.
According to the research of Career International, the main ways for pharmaceutical companies to acquire talents are from multinational companies, large domestic enterprises, similar innovative drug companies and the introduction of overseas talents
.

From the perspective of the manufacturing sector, Career International believes that the industry's demand for CMO and CDMO business entrustment under the MAH system has increased, and the demand for talent in the CMO and CDMO fields has continued to increase.
Pharmaceutical companies in the development stage have set up external quality management positions.
Research shows that there is a large talent gap between quality management managers and directors
.

At the same time, in the context of the epidemic, the overall demand for vaccines has increased significantly.
In order to ensure sufficient and timely supply of vaccines, vaccine companies have built or renovated a large number of vaccine bases in the past year.
Career International believes that this makes The overall demand for talents at the base construction and production and quality management levels has surged; at the same time, in order to increase production capacity, optimize the supply chain, and improve the efficiency and quality of vaccine supply, the demand for GSP quality management positions has also increased, and the demand for GSP quality managers/directors has increased
.

Overall, the talent gap in the manufacturing sector is mainly manifested in positions related to quality analysis, quality director, purification process, and preparation process
.
At present, domestic CMO and CDMO companies generally fill their own talent gaps by means of multinational pharmaceutical companies, large domestic pharmaceutical companies, multinational private CROs and CDMOs, innovative drug companies of the same type, and overseas talent introduction
.

In general, leaders in new drug development and talents with international clinical development experience are the most in-demand talents in the pharmaceutical industry
.
From the perspective of the overall salary situation, the salary in the field of pharmaceutical research and development will still maintain a steady upward growth trend this year, with a natural increase ranging from 30% to 40%, and the salary increase for positions involving research and development and CMC will be higher
.

With the continuous development of China's pharmaceutical innovation talent construction and the improvement of the talent echelon, the flow of talents in China's pharmaceutical industry will become more rational
.

02.
The product has entered commercialization, and the demand for marketing talents of innovative pharmaceutical companies has increased

With the rapid development of the biopharmaceutical industry, the focus of pharmaceutical companies is not only on innovative research and development, but also the marketing of biopharmaceuticals has begun to play an increasingly important role
.
Another new trend is that under the influence of the epidemic, Internet pharmaceutical marketing has flourished, and the scale of the industry has continued to expand, attracting Internet giants and government units at all levels to deploy
.

After the normalization of centralized procurement, hospitals as the core channel for prescription drug sales will be greatly weakened, and pharmaceutical retail may assume an important channel for prescription drug sales.
Therefore, companies gradually shift their sales centers to the retail side, and vigorously expand the out-of-hospital market, including Traditional pharmacy retail and layout of e-commerce channels
.

In the situation of increasingly fierce competition in the pharmaceutical industry, the choice of pharmaceutical marketing model determines the survival and development of pharmaceutical companies.
Innovation and change are particularly important
.

From the perspective of the types of enterprises in demand for talents, the demand for pharmaceutical marketing talents of foreign companies is shrinking, and the demand for pharmaceutical marketing talents of local enterprises is increasing
.
From the perspective of talent demand types, the talent gap of foreign companies is mainly in regional promotion managers, key account managers, regional managers, regional managers, etc.
The talent gap of local pharmaceutical companies is mainly in sales directors, regional directors, marketing directors, post-marketing medical directors, etc.

.

According to the statistics of Career International, sales directors, regional managers, regional managers, regional promotion managers, key account managers, and market access managers will become the main positions in the talent gap.
"Mining" talent
.
The job-hopping increase of these popular positions will be stable at around 10%-20%
.

As more and more innovative drugs enter the commercialization stage from the clinical stage, the demand for marketing talents for innovative pharmaceutical companies is increasing
.
In order to successfully realize commercialization of innovative pharmaceutical companies, the demand for pharmaceutical marketing talents is also increasing sharply
.
Career International believes that innovative drug companies have developed rapidly in recent years, and a large amount of capital has been continuously injected into innovative drug research projects.
With the gradual commercialization of projects, there is a large demand for talents in medicine, marketing, sales, major customers and government affairs
.

From the perspective of the overall salary increase, Career International expects that the salary increase of both foreign-funded and domestic pharmaceutical companies in the pharmaceutical marketing field will be 5%-10%
.
Among them, the salary increase of pharmaceutical positions related to innovative drug business is higher, with a natural increase of 8%-15%, and a job-hopping increase of 20%-30%
.

03.
The epidemic catalyzed Internet medical care to value the background of talents

The outbreak of the new crown epidemic in early 2020 has greatly catalyzed the growth of the domestic Internet medical industry
.

According to the data released by the National Health and Medical Commission in 2020, during the outbreak of the new crown pneumonia, Internet medical care has become one of the important components of medical services.
Only the Internet diagnosis and treatment of hospitals under the National Health and Medical Commission has achieved 17% compared with the same period in 2019.
multiplied
.
At the same time, the volume of diagnosis and treatment consultations on third-party Internet service platforms also increased by more than 20 times compared with the same period, and the number of prescriptions increased by nearly 10 times
.

Whether it is the attitude of support for Internet medical care in the Outline of the Healthy China 2030 Plan, raising health care to a national strategic level, more and more capital attention and investment in the business sector of "Internet + medical care"; The "Guiding Opinions on Promoting the Development of "Internet +" Medical Insurance During the New Coronary Pneumonia Epidemic, jointly issued by the National Health Insurance Bureau and the National Health and Health Commission, included chronic disease "Internet +" review into medical insurance; or the National Health and Health Commission and the State Administration of Traditional Chinese Medicine jointly The "Administrative Measures for Medical Consortiums (Trial)" was issued and proposed to accelerate the construction of medical consortia and gradually realize the grid layout management of medical consortia.
The promulgation of a series of policies has catalyzed the growth of the "Internet + medical care" sector
.
From the perspective of policy guidance and market development prospects, it indicates that the Internet medical sector will receive great attention in the next few years
.

From the perspective of the development stage of the industry, the reasonable business model of the Internet medical industry is still being explored, the demand for talents related to Internet medical care is increasing, and the requirements for talents' ability are gradually improving
.
According to the statistics of Career International, marketing positions and technical positions are currently in short supply
.
Specifically, the demand for talents in technical positions is mainly in first- and second-tier cities, while marketing positions are distributed all over the country
.
From the perspective of talent acquisition channels, technical talents mainly come from various Internet companies
.
Marketing talent sources include medical Internet companies, pharmaceutical and medical device companies.

At present, both large Internet companies, traditional medicine and medical companies are actively deploying the "Internet + big health" industry
.
On the one hand, Internet giants such as Alibaba, JD.
com, and Baidu continue to deepen their efforts in the field of general health and expand the business volume of their Internet hospitals
.
On the other hand, from the early digital innovation business to the recent establishment of the Internet hospital platform business, traditional pharmaceutical companies are also constantly transforming under the influence of the current domestic medical reform environment
.
Due to the reform of medical policies and the rise of technical means such as AI big data, more and more companies involved in "digital therapy" have also drawn a strong stroke on the business map of "Internet + medical care"
.
These growing and improving companies all send strong signals of job transition and demand to the talent market
.

With the continuous expansion and improvement of Internet medical-related businesses, Career International said that under the premise of a large demand for talents, the Internet medical sector-related companies are also constantly improving their requirements for talent ability and quality.
For example, companies no longer use an open The attitude of attracting candidates with traditional Internet or traditional pharmaceutical industry background, but more emphasis on candidates' outstanding "Internet + medical" background and project experience
.

According to the forecast of Career International, the overall salary of the Internet medical industry will still show an upward trend in 2022, but the growth rate will gradually slow down
.
Some more innovative positions, such as digital therapy-related positions, such as the head of digital therapy and behavioral scientists, have higher salary increases, which can reach 30%-50%
.
In addition, from the perspective of talent demand, Beijing, Shanghai, Guangzhou, and Hangzhou have the largest demand for middle and high-level operation, marketing or technical talents
.